SCHEMBL2821892

SCHEMBL2821892

CCC(=O)C(C)N1C(=O)c2ccccc2C1=O

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.60
ALDH1A1 P00352 5/20 0.54
HTT P42858 2/20 0.54
NPC1 O15118 1/20 0.53
KMT2A Q03164 3/20 0.51
GAA P10253 2/20 0.51
MAPT P10636 2/20 0.50
TSHR P16473 2/20 0.50
POLB P06746 2/20 0.50
NPSR1 Q6W5P4 2/20 0.49
KDM4E B2RXH2 2/20 0.49
MEN1 O00255 1/20 0.49
USP2 O75604 1/20 0.49
TP53 P04637 1/20 0.49
GLA P06280 1/20 0.49
CYP3A4 P08684 1/20 0.49
CYP2D6 P10635 1/20 0.49
HPGD P15428 1/20 0.49
ALOX12 P18054 1/20 0.49
NFKB1 P19838 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5656956 0.84 LMNA (0.51) LMNAALDH1A1HTTNPC1KMT2A
SCHEMBL28536859 0.84 LMNA (0.58) LMNAALDH1A1HTTNPC1KMT2A
SCHEMBL13273994 0.83 TP53 (0.57) LMNAALDH1A1HTTNPC1KMT2A
SCHEMBL10577708 0.81 LMNA (0.68) LMNAALDH1A1HTTNPC1KMT2A
SCHEMBL13273978 0.80 TP53 (0.51) LMNAALDH1A1HTTNPC1KMT2A
SCHEMBL11453215 0.80 LMNA (0.54) LMNAALDH1A1HTTKMT2AGAA
SCHEMBL125972 0.79 LMNA (0.71) LMNAALDH1A1HTTNPC1KMT2A
SCHEMBL29472125 0.79 LMNA (0.71) LMNAALDH1A1HTTNPC1KMT2A
SCHEMBL8977751 0.79 LMNA (0.66) LMNAALDH1A1HTTNPC1KMT2A
SCHEMBL7399848 0.79 LMNA (0.71) LMNAALDH1A1HTTNPC1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2226322-B1 IMIDAZOLE CARBONYL COMPOUND DAIICHI SANKYO CO LTD (JP) 2015-01-21 EP disclosed
US-8927588-B2 Imidazole carbonyl compound DAIICHI SANKYO COMPANY, LIMITED (JP) 2015-01-06 US disclosed
US-20140073622-A1 IMIDAZOLE CARBONYL COMPOUND DAIICHI SANKYO COMPANY, LIMITED (JP) 2014-03-13 US disclosed
US-8536197-B2 Imidazole carbonyl compound DAIICHI SANKYO COMPANY, LIMITED (JP) 2013-09-17 US disclosed
US-20100311966-A1 IMIDAZOLE CARBONYL COMPOUND DAIICHI SANKYO COMPANY, LIMITED (JP) 2010-12-09 US disclosed
EP-2226322-A1 IMIDAZOLE CARBONYL COMPOUND Daiichi Sankyo Company, Limited (JP) 2010-09-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100311966-A1 IMIDAZOLE CARBONYL COMPOUND TOP1, TOP2B, TOP2A LMNA 948/4885ALDH1A1 3596/4885HTT 4384/4885
US-20140073622-A1 IMIDAZOLE CARBONYL COMPOUND TOP1, TOP2B, TOP2A LMNA 1119/4885ALDH1A1 1220/4885HTT 4571/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.